World Astatine Community expands access to cancer-fighting At-211

June 20, 2023, 12:00PMNuclear News
Representatives from the U.S., EU, and Japan announce the WAC at the 12th International Symposium for Targeted Alpha Therapy. (Photo: NIDC)

The World Astatine Community (WAC) was formed earlier this year during the 12th International Symposium for Targeted Alpha Therapy by representatives from the United States, Japan, and the European Union to share astatine production technology and advance science and health care. The National Isotope Development Center (NIDC), which is managed by the Department of Energy’s Isotope Program (DOE-IP), announced the news on June 15 and explained how the United States plans to help expand the global supply of astatine-211.

To continue reading, log in or create a free account!

Related Articles

On moving fast and breaking things

March 16, 2026, 9:33AMNuclear NewsCraig Piercy

So much of what is happening in federal nuclear policy these days seems driven by a common approach popularized in the technology sector. Silicon Valley calls it “move fast and break...

Webinar highlights Gen IV reactors

March 16, 2026, 7:31AMANS News

The American Nuclear Society recently hosted a new webinar in its ongoing Educator Training series titled “Perspectives on Generation IV Reactors.” It was led by Edward A. Friedman,...

Aalo Atomics discusses the road ahead

March 12, 2026, 1:13PMNuclear News

Yasir Arafat, president and chief technology officer of Aalo Atomics, participated in the first day of sessions at the Nuclear Regulatory Commission’s annual Regulatory Information...